ecNumber*3.4.24.74#specificActivity*-999#specificActivityMaximum*#commentary*specific activity is expressed as a cytotoxic effect in cell-rounding titers of Ht-29 cells (i.e. colon carcinoma cells)#organism*Bacteroides fragilis#literature*31492#!ecNumber*3.4.24.74#specificActivity*-999#specificActivityMaximum*#commentary*specific activity is expressed as a cytotoxic effect in cell-rounding titers of Ht-29 cells (i.e. colon carcinoma cells)#organism*Bacteroides fragilis#literature*31496#!ecNumber*3.4.24.74#specificActivity*-999#specificActivityMaximum*#commentary*specific activity is expressed as a cytotoxic effect in cell-rounding titers of Ht-29 cells (i.e. colon carcinoma cells)#organism*Bacteroides fragilis#literature*31497#!ecNumber*3.4.24.74#specificActivity*-999#specificActivityMaximum*#commentary*BFT stimulates apoptosis of human colon epithelial cell line HT-29. BFT suppresses apoptosis by increasing the cellular expression of cellular inhibitor of apoptosis protein-2 resulting in a delayed apoptosis#organism*Bacteroides fragilis#literature*697730#!ecNumber*3.4.24.74#specificActivity*-999#specificActivityMaximum*#commentary*purified BFT does not directly stimulate lymphocyte proliferation, dendritic cell stimulation, or Toll-like receptor activation#organism*Bacteroides fragilis#literature*698252#